12/17
08:54 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
Medium
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
12/17
08:37 am
tlsi
Rating for TLSI
Low
Report
Rating for TLSI
12/17
08:36 am
tlsi
TriSalus Life Sciences initiated with an Overweight at Cantor Fitzgerald
Low
Report
TriSalus Life Sciences initiated with an Overweight at Cantor Fitzgerald
11/15
09:26 am
tlsi
Rating for TLSI
Low
Report
Rating for TLSI
11/12
07:49 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
11/12
07:49 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
10/25
09:38 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $12.50 price target on the stock.
Low
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $12.50 price target on the stock.
10/25
09:04 am
tlsi
TriSalus Life Sciences initiated with bullish view at Northland
Medium
Report
TriSalus Life Sciences initiated with bullish view at Northland